Last 537.40 INR
Change Today -7.90 / -1.45%
Volume 20.6K
SLPA On Other Exchanges
Symbol
Exchange
Natl India
As of 6:06 AM 12/17/14 All times are local (Market data is delayed by at least 15 minutes).

shilpa medicare ltd (SLPA) Snapshot

Open
549.00
Previous Close
545.30
Day High
552.00
Day Low
525.25
52 Week High
10/1/14 - 585.00
52 Week Low
01/28/14 - 239.05
Market Cap
20.7B
Average Volume 10 Days
13.5K
EPS TTM
21.36
Shares Outstanding
38.6M
EX-Date
09/11/14
P/E TM
25.2x
Dividend
1.00
Dividend Yield
0.19%
Current Stock Chart for SHILPA MEDICARE LTD (SLPA)

Related News

No related news articles were found.

shilpa medicare ltd (SLPA) Related Businessweek News

No Related Businessweek News Found

shilpa medicare ltd (SLPA) Details

Shilpa Medicare Limited manufactures and sells bulk drugs in India. It offers active pharmaceutical ingredients, intermediates (APIs), formulations, drug delivery systems, peptides/biotech products, specialty chemicals, etc. The company provides its APIs, intermediates, and formulations in the therapeutic areas of oncology, anti-retroviral, multiple sclerosis, immunosuppressant therapies, etc. Shilpa Medicare Limited also exports its products to the United States, Canada, Australia, and Japan; European countries, such as Germany, Switzerland, the Netherlands, Belgium, Spain, Greece, Cyprus, Italy, the United Kingdom, etc.; South American countries, including Mexico, Brazil, Columbia, etc.; African countries comprising Kenya, Nigeria, West Indies, etc.; and Asian countries consisting of Singapore, Taiwan, China, Malaysia, and Thailand. The company was founded in 1987 and is based in Raichur, India.

Founded in 1987

shilpa medicare ltd (SLPA) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

shilpa medicare ltd (SLPA) Key Developments

Shilpa Medicare Limited Reports Consolidated and Standalone Earnings Results for the Second Quarter and Six Months Ended September 30, 2014

Shilpa Medicare Limited reported consolidated and standalone earnings results for the second quarter and six months ended September 30, 2014. For the quarter, standalone total income from operations was INR 1,433.549 million, profit from operations before other income, finance costs and exceptional items was INR 269.915 million, net profit was INR 220.829 million or INR 5.73 per basic and diluted after extraordinary items (not annualized) against total income from operations was INR 1,276.148 million, profit from operations before other income, finance costs and exceptional items was INR 224.69 million, net profit was INR 176.293 million or INR 4.79 per basic and diluted after extraordinary items (not annualized) a year ago. Profit from ordinary activities before tax was INR 280.427 million compared to INR 231.998 million a year ago. For the quarter, consolidated total income from operations was INR 1,536.624 million, profit from operations before other income, finance costs and exceptional items was INR 225.832 million, net profit was INR 171.594 million or INR 4.50 per basic and diluted after extraordinary items (not annualized) against total income from operations was INR 1,358.973 million, profit from operations before other income, finance costs and exceptional items was INR 182.005 million, net profit was INR 130.934 million or INR 3.70 per basic and diluted after extraordinary items (not annualized) a year ago. Profit from ordinary activities before tax was INR 237.001 million compared to INR 186.051 million a year ago. For the six-month period, standalone total income from operations was INR 2,700.809 million, profit from operations before other income, finance costs and exceptional items was INR 527.609 million, net profit was INR 411.222 million or INR 10.67 per basic and diluted after extraordinary items (not annualized) against total income from operations was INR 2,305.286 million, profit from operations before other income, finance costs and exceptional items was INR 382.497 million, net profit was INR 344.693 million or INR 9.37 per basic and diluted after extraordinary items (not annualized) a year ago. Profit from ordinary activities before tax was INR 543.143 million compared to INR 427.828 million a year ago. For the six-month period, consolidated total income from operations was INR 2,925.643 million, profit from operations before other income, finance costs and exceptional items was INR 465.685 million, net profit was INR 339.45 million or INR 8.93 per basic and diluted after extraordinary items (not annualized) against total income from operations was INR 2,495.906 million, profit from operations before other income, finance costs and exceptional items was INR 340.761 million, net profit was INR 299.171 million or INR 8.24 per basic and diluted after extraordinary items (not annualized) a year ago. Profit from ordinary activities before tax was INR 476.899 million compared to INR 381.466 million a year ago.

Shilpa Medicare Limited to Report Q2, 2015 Results on Nov 14, 2014

Shilpa Medicare Limited announced that they will report Q2, 2015 results on Nov 14, 2014

Shilpa Medicare Limited, Board Meeting, Nov 14, 2014

Shilpa Medicare Limited, Board Meeting, Nov 14, 2014. Agenda: To consider the un-audited financial results for the quarter ended September 30, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SLPA:IN 537.40 INR -7.90

SLPA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for SLPA.
View Industry Companies
 

Industry Analysis

SLPA

Industry Average

Valuation SLPA Industry Range
Price/Earnings 25.9x
Price/Sales 3.2x
Price/Book 3.9x
Price/Cash Flow 19.7x
TEV/Sales 2.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SHILPA MEDICARE LTD, please visit www.vbshilpa.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.